Avsola 100 MG Injection
- RxCUI
- 2266530
- RxNorm name
- Avsola 100 MG Injection
- Display name
- Avsola 100 MG Injection
- Full name
- Avsola 100 MG Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761086 | Avsola | infliximab-axxq | 351(k) Biosimilar | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AVSOLA | INFLIXIMAB-AXXQ | Amgen, Inc | de34bcb7-b524-45c8-9181-61c6f48d540e | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | 2266530 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| de34bcb7-b524-45c8-9181-61c6f48d540e | AVSOLA 100 MG Injection [PSN] · infliximab-axxq 100 MG Injection [Avsola] [SBD] · Avsola 100 MG Injection [SY] | 3 | 18 | These highlights do not include all the information needed to use AVSOLA ® safely and effectively. See full prescribing information for AVSOLA. AVSOLA (infliximab-axxq) for injection, for intravenous use Initial U.S. Approval: 2019 AVSOLA (infliximab-axxq) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwe | 20250908 |